Next-generation AI is transforming research and development by enabling:
- Scalable insights from multi-modal datasets
- In silico experimentation powered by machine learning and foundation models
- Generative AI for novel molecule design
- Automated workflows through agentic systems and robotics
These innovations are already accelerating speed and reducing cost in R&D. But beyond efficiency, AI presents a deeper opportunity: advancing scientific understanding of diseases and drugs. By keeping human scientists actively in the loop, AI can provide oversight, foster discovery, and open entirely new therapeutic avenues.
In this session, we will explore how modern AI tools can “close the knowledge loop”—moving from automation and efficiency toward true scientific insight and discovery.
Sponsor(s):
McKinsey & Company
Speaker(s):

Chris Anagnostopoulos
Tech Fellow Partner
McKinsey & Company
Time:
9:15am - 9:45am
Session Type:
Keynote